Form 4 for COGT Cogent Biosciences, Inc.
Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-16 · accession 0001104659-22-072798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-06-21 | 2022-06-16 | COGT | Fairmount Funds Management LLC | 10%, See Remarks | P - Purchase | $8.25 | +1.20M | 2.47M | +94% | +$9.90M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-16 | P | A | 1,200,000 | $8.25 | 2,472,124 | I Fairmount Healthcare Fund II LP | — | — | (F2) Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein. |